Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mabrouk M. Elgadi
Boosted Tipranavir Versus Darunavir in Treatment-Experienced Patients
Drugs in R and D
Pharmacology
Related publications
Real-Life Study of Dual Therapy Based on Dolutegravir and Ritonavir-Boosted Darunavir in HIV-1-infected Treatment-Experienced Patients
PLoS ONE
Multidisciplinary
Effectiveness and Safety of Dual Therapy With Rilpivirine and Boosted Darunavir in Treatment-Experienced Patients With Advanced HIV Infection: A Preliminary 24 Week Analysis (RIDAR Study)
BMC Infectious Diseases
Infectious Diseases
Clinical Validation and Applicability of Different Tipranavir/Ritonavir Genotypic Scores in HIV-1 Protease Inhibitor-Experienced Patients
Current HIV Research
Virology
Infectious Diseases
Effects of Tipranavir, Darunavir, and Ritonavir on Platelet Function, Coagulation, and Fibrinolysis in Healthy Volunteers
Current HIV Research
Virology
Infectious Diseases
Darunavir Exhibits a Potent Activity as Boosted PI in Subjects on a Salvage Antiretroviral Regimen
Journal of the International AIDS Society
Environmental
Public Health
Infectious Diseases
Occupational Health
Comparative Effectiveness of Darunavir 1,200 Mg Daily and Approved Dosing Strategies for Protease Inhibitor-Experienced Patients
AIDS Research and Treatment
Immunology
Public Health
Allergy
Environmental
Dermatology
Infectious Diseases
Occupational Health
Darunavir: Review of Its Efficacy as a Therapeutic Option for Treatment-Naïve and Treatment-Experienced Adults and Adolescents
Clinical Medicine Reviews in Therapeutics
Abacavir/Lamivudine Versus Tenofovir/Emtricitabine in Virologically Suppressed Patients Switching From Ritonavir-Boosted Protease Inhibitors to Raltegravir
AIDS Research and Human Retroviruses
Virology
Infectious Diseases
Immunology
Pegylated-Interferon Alpha Therapy for Treatment-Experienced Chronic Hepatitis B Patients
PLoS ONE
Multidisciplinary
